298 related articles for article (PubMed ID: 31661359)
1. Recognizing Persistent Disease in Well-Differentiated Thyroid Cancer and Association with Lymph Node Yield and Ratio.
Noel JE; Orloff LA
Otolaryngol Head Neck Surg; 2020 Jan; 162(1):50-55. PubMed ID: 31661359
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
3. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence.
Pingpank JF; Sasson AR; Hanlon AL; Friedman CD; Ridge JA
Arch Otolaryngol Head Neck Surg; 2002 Nov; 128(11):1275-8. PubMed ID: 12431169
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
5. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
6. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
8. Metastatic papillary thyroid cancer with lateral neck disease: pattern of spread by level.
Merdad M; Eskander A; Kroeker T; Freeman JL
Head Neck; 2013 Oct; 35(10):1439-42. PubMed ID: 22965902
[TBL] [Abstract][Full Text] [Related]
9. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
10. Extent of lateral neck dissection for papillary thyroid microcarcinomas.
Lee JH; Chun YS; Chung YS
Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753
[TBL] [Abstract][Full Text] [Related]
11. Selective lateral compartment neck dissection for thyroid cancer.
Welch K; McHenry CR
J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
[TBL] [Abstract][Full Text] [Related]
12. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.
Heaton CM; Chang JL; Orloff LA
Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749
[TBL] [Abstract][Full Text] [Related]
14. The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.
Rajeev P; Ahmed S; Ezzat TM; Sadler GP; Mihai R
Langenbecks Arch Surg; 2013 Mar; 398(3):377-82. PubMed ID: 23274361
[TBL] [Abstract][Full Text] [Related]
15. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
16. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
17. Determining the extent of lateral neck dissection necessary to establish regional disease control and avoid reoperation after previous total thyroidectomy and radioactive iodine for papillary thyroid cancer.
Wu G; Fraser S; Pai SI; Farrag TY; Ladenson PW; Tufano RP
Head Neck; 2012 Oct; 34(10):1418-21. PubMed ID: 22052539
[TBL] [Abstract][Full Text] [Related]
18. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
[TBL] [Abstract][Full Text] [Related]
19. Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
Yu ST; Ge JN; Sun BH; Wei ZG; Xiao ZZ; Zhang ZC; Chen WS; Li TT; Lei ST
Oral Oncol; 2021 Dec; 123():105567. PubMed ID: 34710736
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
Son HJ; Kim JK; Jung YD; Jang GH; Seo YT; Kim DS; Park SH; Jeong YJ
Head Neck; 2018 Nov; 40(11):2449-2454. PubMed ID: 30302890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
